
Tamthom Ngo Truong
Examiner (ID: 15643)
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1202, 1624, 1611, 2899 |
| Total Applications | 1039 |
| Issued Applications | 654 |
| Pending Applications | 109 |
| Abandoned Applications | 276 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7306092
[patent_doc_number] => 20040116418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-17
[patent_title] => 'Compounds and methods for inhibition of HIV and related viruses'
[patent_app_type] => new
[patent_app_number] => 10/725657
[patent_app_country] => US
[patent_app_date] => 2003-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28466
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0116/20040116418.pdf
[firstpage_image] =>[orig_patent_app_number] => 10725657
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/725657 | Compounds and methods for inhibition of HIV and related viruses | Nov 30, 2003 | Abandoned |
Array
(
[id] => 7337075
[patent_doc_number] => 20040132725
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-08
[patent_title] => 'PDGF receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same'
[patent_app_type] => new
[patent_app_number] => 10/715547
[patent_app_country] => US
[patent_app_date] => 2003-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 19396
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20040132725.pdf
[firstpage_image] =>[orig_patent_app_number] => 10715547
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/715547 | PDGF receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same | Nov 18, 2003 | Abandoned |
Array
(
[id] => 7347247
[patent_doc_number] => 20040192711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-30
[patent_title] => 'Therapeutic compounds'
[patent_app_type] => new
[patent_app_number] => 10/715773
[patent_app_country] => US
[patent_app_date] => 2003-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 55
[patent_figures_cnt] => 55
[patent_no_of_words] => 23095
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20040192711.pdf
[firstpage_image] =>[orig_patent_app_number] => 10715773
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/715773 | Therapeutic compounds | Nov 16, 2003 | Abandoned |
Array
(
[id] => 7469661
[patent_doc_number] => 20040102463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-27
[patent_title] => 'N- (3-ethynylphenyl) -6, 7-bis (2-methoxyethoxy) -4-quinazolinamine mesylate anhydrate and monohydrate'
[patent_app_type] => new
[patent_app_number] => 10/716098
[patent_app_country] => US
[patent_app_date] => 2003-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4822
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0102/20040102463.pdf
[firstpage_image] =>[orig_patent_app_number] => 10716098
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/716098 | N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine mesylate anhydrate and monohydrate | Nov 16, 2003 | Issued |
Array
(
[id] => 7347247
[patent_doc_number] => 20040192711
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-09-30
[patent_title] => 'Therapeutic compounds'
[patent_app_type] => new
[patent_app_number] => 10/715773
[patent_app_country] => US
[patent_app_date] => 2003-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 55
[patent_figures_cnt] => 55
[patent_no_of_words] => 23095
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20040192711.pdf
[firstpage_image] =>[orig_patent_app_number] => 10715773
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/715773 | Therapeutic compounds | Nov 16, 2003 | Abandoned |
Array
(
[id] => 356386
[patent_doc_number] => 07488823
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-02-10
[patent_title] => 'Cyanoguanidines and cyanoamidines as ErbB2 and EGFR inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/704120
[patent_app_country] => US
[patent_app_date] => 2003-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13314
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 4
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/488/07488823.pdf
[firstpage_image] =>[orig_patent_app_number] => 10704120
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/704120 | Cyanoguanidines and cyanoamidines as ErbB2 and EGFR inhibitors | Nov 9, 2003 | Issued |
Array
(
[id] => 7474555
[patent_doc_number] => 20040097503
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-20
[patent_title] => 'Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators of caspases and inducers of apoptosis and the use thereof'
[patent_app_type] => new
[patent_app_number] => 10/704448
[patent_app_country] => US
[patent_app_date] => 2003-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 45136
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0097/20040097503.pdf
[firstpage_image] =>[orig_patent_app_number] => 10704448
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/704448 | Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators of caspases and inducers of apoptosis and the use thereof | Nov 9, 2003 | Issued |
Array
(
[id] => 668541
[patent_doc_number] => 07094782
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-08-22
[patent_title] => 'Azolo triazines and pyrimidines'
[patent_app_type] => utility
[patent_app_number] => 10/703235
[patent_app_country] => US
[patent_app_date] => 2003-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57276
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/094/07094782.pdf
[firstpage_image] =>[orig_patent_app_number] => 10703235
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/703235 | Azolo triazines and pyrimidines | Nov 6, 2003 | Issued |
Array
(
[id] => 5711000
[patent_doc_number] => 20060052345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'Quinazolinone compounds as calcilytics'
[patent_app_type] => utility
[patent_app_number] => 10/531161
[patent_app_country] => US
[patent_app_date] => 2003-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 20330
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20060052345.pdf
[firstpage_image] =>[orig_patent_app_number] => 10531161
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/531161 | Quinazolinone compounds as calcilytics | Nov 3, 2003 | Abandoned |
Array
(
[id] => 569752
[patent_doc_number] => 07462623
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-12-09
[patent_title] => 'Quinazoline derivatives as Src tyrosine kinase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/533931
[patent_app_country] => US
[patent_app_date] => 2003-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42351
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/462/07462623.pdf
[firstpage_image] =>[orig_patent_app_number] => 10533931
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/533931 | Quinazoline derivatives as Src tyrosine kinase inhibitors | Oct 28, 2003 | Issued |
Array
(
[id] => 121802
[patent_doc_number] => 07709491
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-04
[patent_title] => 'Substituted quinazolines as antiviral agents, especially against cytomegaloviruses'
[patent_app_type] => utility
[patent_app_number] => 10/534138
[patent_app_country] => US
[patent_app_date] => 2003-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10582
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/709/07709491.pdf
[firstpage_image] =>[orig_patent_app_number] => 10534138
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/534138 | Substituted quinazolines as antiviral agents, especially against cytomegaloviruses | Oct 24, 2003 | Issued |
Array
(
[id] => 7136311
[patent_doc_number] => 20040044013
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-04
[patent_title] => '1-dimercaptoalkylquinazolin-2,4(1h,3h)-diones as matrix metalloproteinase (mmp) inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/250988
[patent_app_country] => US
[patent_app_date] => 2003-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3313
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20040044013.pdf
[firstpage_image] =>[orig_patent_app_number] => 10250988
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/250988 | 1-dimercaptoalkylquinazolin-2,4(1h,3h)-diones as matrix metalloproteinase (mmp) inhibitors | Oct 21, 2003 | Abandoned |
Array
(
[id] => 7281356
[patent_doc_number] => 20040063733
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-01
[patent_title] => 'Quinazoline derivatives'
[patent_app_type] => new
[patent_app_number] => 10/415053
[patent_app_country] => US
[patent_app_date] => 2003-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22715
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20040063733.pdf
[firstpage_image] =>[orig_patent_app_number] => 10415053
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/415053 | Quinazoline derivatives | Oct 21, 2003 | Abandoned |
Array
(
[id] => 7310597
[patent_doc_number] => 20040142942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-22
[patent_title] => 'Gonadotropin-releasing hormone receptor antagonists and methods relating thereto'
[patent_app_type] => new
[patent_app_number] => 10/690222
[patent_app_country] => US
[patent_app_date] => 2003-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12887
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20040142942.pdf
[firstpage_image] =>[orig_patent_app_number] => 10690222
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/690222 | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto | Oct 19, 2003 | Abandoned |
Array
(
[id] => 7337121
[patent_doc_number] => 20040132732
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-08
[patent_title] => 'Quinazolinones and derivatives thereof as factor Xa inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/687421
[patent_app_country] => US
[patent_app_date] => 2003-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25724
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20040132732.pdf
[firstpage_image] =>[orig_patent_app_number] => 10687421
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/687421 | Quinazolinones and derivatives thereof as factor Xa inhibitors | Oct 15, 2003 | Abandoned |
Array
(
[id] => 7291236
[patent_doc_number] => 20040110777
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-10
[patent_title] => 'Quinazolinones and pyridinylpyrimidinones for controlling invertebrate pests'
[patent_app_type] => new
[patent_app_number] => 10/433368
[patent_app_country] => US
[patent_app_date] => 2003-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 81658
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20040110777.pdf
[firstpage_image] =>[orig_patent_app_number] => 10433368
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/433368 | Quinazolinones and pyridinylpyrimidinones for controlling invertebrate pests | Oct 13, 2003 | Abandoned |
Array
(
[id] => 5694795
[patent_doc_number] => 20060154942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-13
[patent_title] => 'Quinazolinone derivatives useful as anti-hyperalgesic agents'
[patent_app_type] => utility
[patent_app_number] => 10/530897
[patent_app_country] => US
[patent_app_date] => 2003-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8306
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0154/20060154942.pdf
[firstpage_image] =>[orig_patent_app_number] => 10530897
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/530897 | Quinazolinone derivatives useful as anti-hyperalgesic agents | Oct 9, 2003 | Abandoned |
Array
(
[id] => 7677154
[patent_doc_number] => 20040152672
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-08-05
[patent_title] => 'Indole compounds useful for the treatment of cancer'
[patent_app_type] => new
[patent_app_number] => 10/682790
[patent_app_country] => US
[patent_app_date] => 2003-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 9957
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20040152672.pdf
[firstpage_image] =>[orig_patent_app_number] => 10682790
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/682790 | Indole compounds useful for the treatment of cancer | Oct 8, 2003 | Abandoned |
Array
(
[id] => 7281313
[patent_doc_number] => 20040063690
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-01
[patent_title] => 'Substituted 4-amino-2-aryl-tetrahydroquinazolines, their preparation, their use and pharmaceutical preparations comprising them'
[patent_app_type] => new
[patent_app_number] => 10/674350
[patent_app_country] => US
[patent_app_date] => 2003-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9565
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20040063690.pdf
[firstpage_image] =>[orig_patent_app_number] => 10674350
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/674350 | Substituted 4-amino-2-aryl-tetrahydroquinazolines, their preparation, their use and pharmaceutical preparations comprising them | Sep 30, 2003 | Issued |
Array
(
[id] => 278040
[patent_doc_number] => 07557115
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-07-07
[patent_title] => 'Compounds, compositions, and methods'
[patent_app_type] => utility
[patent_app_number] => 10/529745
[patent_app_country] => US
[patent_app_date] => 2003-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20204
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/557/07557115.pdf
[firstpage_image] =>[orig_patent_app_number] => 10529745
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/529745 | Compounds, compositions, and methods | Sep 29, 2003 | Issued |